Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

CONIVAPTAN HYDROCHLORIDE

Standard Dose
20MG/100ML (0.2MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER is listed in Drugs@FDA under application 021697 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CONIVAPTAN HYDROCHLORIDE Form and strength INJECTABLE;INTRAVENOUS - 20MG/100ML (0.2MG/ML) Sponsor CUMBERLAND Submission history Latest submission status date: 2016-10-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER is listed in Drugs@FDA under application 021697 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CONIVAPTAN HYDROCHLORIDE Form and strength INJECTABLE;INTRAVENOUS - 20MG/100ML (0.2MG/ML) Sponsor CUMBERLAND Submission history Latest submission status date: 2016-10-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.